For the Inventor, By the Inventor

Enter assignee name

Redwood City, CA, United States of America

Genomic Health, Inc.

USPTO Granted Patents = 59

CIPO Patents = 99

EPO Patents = 45

Trademarks = 28

Forward Citations = 1,028

Loading Chart...

Loading Chart...

84 inventors (with patents filed for the assignee):

Joffre B Baker (44 out of 44 patents)

Steven Shak (24 out of 24 patents)

Soonmyung Paik (19 out of 20 patents)

4. Wayne Cowens (16 out of 16 patents)

5. Michael C Kiefer (15 out of 43 patents)

6. Maureen T Cronin (14 out of 28 patents)

7. James Hackett (14 out of 16 patents)

8. Drew Watson (13 out of 13 patents)

9. Tara Maddala (10 out of 10 patents)

10. Steve Shak (10 out of 10 patents)

11. Dejan Knezevic (9 out of 9 patents)

12. John L Bryant (8 out of 10 patents)

13. Kim Clark (8 out of 8 patents)

14. Michael R Crager (7 out of 7 patents)

15. Audrey Goddard (7 out of 632 patents)

Core Competencies:

Gene Expression Profiling

Cancer Prognosis

RNA Depletion Methods

DNA Methylation Analysis

Cancer Recurrence Prediction

Biopsied Tumor Analysis

Gene Expression Markers

Prostate Cancer Prognosis

Breast Cancer Prognosis

Colorectal Cancer Prognosis

Chemotherapy Response Prediction

Gene Fusion Analysis

59 patents: Sort by Forward Citations

1. 12412642 - Method to use gene expression to determine likelihood of clinical outcome of renal cancer (2025-09-09),

2. 11807900 - Systems and methods for pre-analytical substrate processing (2023-11-07),

3. 11776664 - Method to use gene expression to determine likelihood of clinical outcome of renal cancer (2023-10-03),

4. 11649506 - DNA methylation and mutational analysis methods for bladder cancer surveillance (2023-05-16),

5. 11551782 - Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancer (2023-01-10),

6. 11220715 - Gene expression markers for breast cancer prognosis (2022-01-11),

7. 11149297 - Methods for depleting RNA from nucleic acid samples (2021-10-19),

8. 11011252 - Gene expression profile algorithm and test for determining prognosis of prostate cancer (2021-05-18),

9. 10892038 - Method to use gene expression to determine likelihood of clinical outcome of renal cancer (2021-01-12),

10. 10619215 - Prediction of likelihood of cancer recurrence (2020-04-14),

11. 10260104 - Method for using gene expression to determine prognosis of prostate cancer (2019-04-16),

12. 10241114 - Gene expression profiling in biopsied tumor tissues (2019-03-26),

13. 10181008 - Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancer (2019-01-15),

14. 10179936 - Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer and response to chemotherapy (2019-01-15),

15. 10169530 - Gene fusions and alternatively spliced junctions associated with breast cancer (2019-01-01),

Genomic Health, Inc. is a precision medicine company dedicated to transforming patient care through molecular diagnostics. With a focus on oncology, their innovative genomic tests help guide treatment decisions and enable personalized healthcare. They provide actionable genomic information to help healthcare professionals optimize cancer care, improve patient outcomes, and reduce healthcare costs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

59 Patents

#30 in Redwood City, CA

#1,388 in California

#5,862 in US

#11,820 in the World

Redwood City, CA, United States of America

Genomic Health, Inc.

Forward Citations = 1,028

84 inventors:

Joffre B Baker (44 out of 44 patents)

Steven Shak (24 out of 24 patents)

Soonmyung Paik (19 out of 20 patents)

4. Wayne Cowens (16 out of 16 patents)

5. Michael C Kiefer (15 out of 43 patents)

Please report any incorrect information to support@idiyas.com

Loading…